A prognostic model for transplant-free survival in secondary-sclerosing cholangitis
Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · e691-e693
DOI: 10.1055/s-0044-1789842 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von G. Konstantis und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Objective: Secondary sclerosing cholangitis (SSC) represents a disease with a dismal prognosis, increasingly diagnosed in clinical settings. Currently, the precise clinical, laboratory, and endoscopic markers associated with a poorer prognosis remain unclear. The primary aim of this study was to identify factors correlated with transplant-free survival in SSC patients and to formulate a novel, widely applicable prognostic model for this endpoint. The model was constructed utilizing easily obtainable clinical and laboratory data, with the overarching goal of enhancing prognostic accuracy in predicting transplant-free survival in individuals with SSC. Table. 1 Total (n=47) Death/LT (n=20) Transplant-free survivors (n=27) P-Value Aetiology 39 SSC-CIP 8 other 16 SSC-CIP 4 other 23 SSC-CIP 4 other Age (years) at initial diagnosis 48(32 – 61) 49 (41-63.5) 45(31-53) 0.12 Cholangitis 38.3% (18/47) 55% (11/20) 25.9% (7/27) 0.04 Biliary cast syndrome 48.94% (23/47) 40% (8/20) 55.5% (15/27) 0.29 Stent 21.28% (10/47) 35% (7/20) 11.1% (3/27) 0.04 Balloon dilatation 51.06% (24/47) 65% (13/20) 40.7% (11/27) 0.10 Gender (male/female) 32/15 14/6 18/9 0.80 Laboratory parameters median (IQR) Platelets (1/fl) 298 [221, 392] 295 [199, 441.5] 298 [221, 383] 0.86 INR 1.06 [0.95, 1.2] 1.1 [1.0, 1.2] 1.0 [0.94, 1.2] 0.24 AST (U/L) 115 [65, 174] 102 [86, 178] 87 [60, 146] 0.11 ALT (U/L) 94 [65, 146] 108 [65.5, 195.5] 115 [65, 156] 0.86 γGT (U/L) 617 [329, 921] 659.5 [372.5, 941] 604 [293, 902] 0.50 AP (U/L) 609 [359, 900] 776 [348, 1043.5] 578 [359, 814] 0.35 Albumin (mg/dL) 3.8 [3.2, 4.2] 3.5 [3.2, 3.8] 4.0 [3.2, 4.5] 0.07 Serum creatinine (mg/dL) 0.8 [0.7, 0.97] 0.79 [0.65, 1.0] 0.81 [0.72, 0.96] 0.91 Total bilirubin (mg/dL) 4.6 [1.2, 12.9] 9.65 [1.6, 14.95] 3.3 [1.1, 10.7] 0.14 CRP (mg/dl) 1.8 [0.5, 5.2] 2.65 [ 0.65, 6.3] 1.3 [ 0.5, 4.3] 0.28 Design: A cohort consisting of 53 SSC-patients was retrospectively analyzed for clinical, biochemical, and endoscopic variables. Kaplan-Meier survival curves, log-rank tests, and univariate Cox proportional hazards models were employed to assess associations with transplant-free survival. A multivariable Cox regression model was then constructed using Lasso regularization and validated with Bootstrap resampling. The model's performance was assessed using the C-statistic for discrimination, while calibration accuracy was established by comparing predicted curves with Kaplan-Meier estimates. Table. 2 Univariable analysis Multivariable analysis OR [95% CI] P OR [95% CI] P Age (> 47 years) 2.69 [1.02, 7.06] 0.04 6.07 [1.63, 22.5] 0.007 Female sex [presence] 0.82 [0.31 2.15] 0.7 INR 3.22 [1.09, 9.53] 0.03 5.61 [1.38, 22.7] 0.016 Total bilirubin (mg/dL) 1.04 [0.99, 1.09] 0.105 Cholangitis 2.46 [1.005 6.06] 0.07 1.47 [0.53, 4.06] 0.450 Serum creatinine (mg/dL) 0.57 [0.11, 2.90] 0.50 Stenting 2.89 [1.13 7.38] 0.03 2.46 [0.82, 7.33] 0.105 AP 0.99 [0.99, 1] 0.5 Biliary cast syndrome 0.74 [0.30 1.83] 0.5 Albumin (mg/dL) 0.52 [0.28, 0.97] 0.04 0.34 [ 0.12, 0.93] 0.03 Platelets (1/fl) 1.0 [0.99, 1.00] 0.1 Gamma GT 1.0 [0.99, 1.0] 0.2 Balloon dilatation 1.28 [0.5, 3.2] 0.6 AST 0.99 [0.9, 1.0] 0.9 ALT 0.99 [0.9, 1.0] 0.7 CRP 1.02 [0.94 , 1.11] 0.5 Results: The final model included the variables: age at SSC diagnosis, albumin, INR, the occurrence of at least one bacterial cholangitis episode, and the insertion of a stent in the bile ductsThe C-statistic was 78.5 (95% CI 65.6 to 91.4). Calibration demonstrated satisfactory performance. Moreover, in our cohort, the model exceeded the prognostic performance of the MELD score. Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion: We examined the clinical, endoscopic, and laboratory characteristics of SSC patients. A precise and high-performing predictive nomogram was successfully developed. This nomogram has the potential to assist clinicians in making personalized decisions and guiding clinical treatment for liver transplant recipients. Publication History Article published online: 26 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Konstantis, G., Moghadam, D. G. L., Frey, A., Schmidt, H., Lange, C. M., Schramm, C., Nuruzade, N., Gerges, C., Willuweit, K., Passenberg, M., & Rashidi-Alavijeh, J. (2024). A prognostic model for transplant-free survival in secondary-sclerosing cholangitis. Zeitschrift für Gastroenterologie, 62(09), e691-e693. https://doi.org/10.1055/s-0044-1789842
Vancouver
Konstantis G, Moghadam DGL, Frey A, Schmidt H, Lange CM, Schramm C, et al. A prognostic model for transplant-free survival in secondary-sclerosing cholangitis. Zeitschrift für Gastroenterologie. 2024;62(09):e691-e693. doi:10.1055/s-0044-1789842
BibTeX
@article{Konstantis2024,
author = {Konstantis, G. and Moghadam, D. G. Loy and Frey, A. and Schmidt, H. and Lange, C. M. and Schramm, C. and Nuruzade, N. and Gerges, C. and Willuweit, K. and Passenberg, M. and Rashidi-Alavijeh, J.},
title = {A prognostic model for transplant-free survival in secondary-sclerosing cholangitis},
journal = {Zeitschrift für Gastroenterologie},
year = {2024},
volume = {62},
number = {09},
pages = {e691--e693},
doi = {10.1055/s-0044-1789842}
}
EUVIMED